Multi-gene test can help identify early breast cancer patients who can safely be spar
Researchers have shown for the first time that it is possible to use a multi-gene test to identify patients with early breast cancer who can be spared chemotherapy and who will still be alive and well five years after diagnosis.
Linear Mode
